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Abstract
Background: The importance of prediabetes and prehypertension has been demonstrated in
several studies especially for primary prevention of CVD. A recent community based cross-
sectional study revealed that 40.9 percent Omani adults are prediabetics. This study was
undertaken to estimate the prevalence of prehypertension and associated cardiovascular risk
profiles in prediabetics. To best of our knowledge, this is the first report on this subject.
Methods: The study included 327 confirmed pre-diabetic Omani adults, who were analysed for
their demographic, metabolic and behavioral characteristics. These characteristics were compared
between the three different blood pressure groups to determine the CVD risk factors. Univariate
and step-wise multiple logistic regression methods were used to carry out the analysis of the data.
Results: In this study, the prevalence of prehypertension was 54.1 percent. Males were at higher
risk of developing prehypertension as compared to females (OR = 2.30, 95% CI: 1.21, 4.38; P <
0.01). The individuals with higher BMI have two fold more risk of developing prehypertension (OR
= 2.25, 95% CI: 1.26, 4.02; P < 0.01). The increased level of OGT enhanced the risk of developing
prehypertension (OR = 1.26, 95% CI: 1.06, 1.50; P < 0.01).
Conclusion: A high prevalence of prehypertension (54.1%) exists in this study population. The
major determinants of prehypertension in these prediabetic subjects were male gender, increasing
dysglycemia and BMI. Appropriate intervention strategies have been suggested.
Background
Sultanate of Oman has been successful in reducing com-
municable diseases and increasing life expectancy at birth
to 76 years for females and 71 years for males. Rapid cul-
tural changes and social advances since 1970 have led to
the manifestation of wide range of non-communicable
diseases [1]. A high prevalence of diabetes (11.6%), obes-
ity (20.5%), hypertension (27.0%) and metabolic syn-
drome (21.0%) exists in Omani population particularly
in urban dweller and older individuals [1-4]. Obesity is
recognized as independent risk factor for hypertension,
diabetes mellitus and dyslipidaemia, which are also
known to be independent risk factors for cardiovascular
diseases (CVD) [5,6].
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It has been documented that the patients with diabetes
have twice the risk of incidence of myocardial infarction
and stroke as that of the general population. As many as
80 percent of patients with type 2 diabetes mellitus will
develop and possibly die of macro vascular diseases. This
represents a great societal cost with major loss of life
expectancy and quality of life [7]. Recent studies have
demonstrated that individuals in prediabatic state can be
identified and diabetes can be delayed if not prevented
[8]. Similarly, the prehypertension category is designed to
focus physicians, patients and public attention on blood
pressure (BP) in the 120–139 mm Hg systolic and/or 80–
89 mm Hg diastolic range with the aim to slow down or
prevent the progression of rising blood pressure, arterial
stiffness and kidney damage that occurs over time [9].
In a recent community-based cross-sectional study, car-
ried out in a semi-urban locality in Oman, revealed that
40.9% of the study subjects were prediabatics. In this
study, all the non-diabetic Omani adults (18 years and
above) residents of Wilayat (district) of Bidbid were
screened for prediabetes based on impaired fasting glu-
cose (IFG) and oral glucose tolerance test (OGTT). The
study included impaired glucose tolerance (IGT; 2_h glu-
cose 7.8 – 11.0 mmol/l), impaired fasting glucose (IFG;
fasting glucose 5.6–6.9 mmol/l) as per American Diabetes
Association (ADA) criteria [10].
The strong Heart Study reported that the prevalence of
prehypertension among diabetics to be 59.4% as com-
pared to 48.2% in non-diabetic participants. Impaired
fasting glucose and impaired glucose tolerance also
greatly increased cardiovascular disease risk in prehyper-
tensive adults without apparent association with incident
cardiovascular disease among normotensive participants
[11]. In San Antonia Heart Study, 1440 prehypertensive
subjects were followed up for 8 years. Hypertension devel-
oped in 130 subjects (9.03%). Clustering of atherogenic
changes associated with hypertension actually preceded
the development of hypertension [12]. Moreover, the
adverse consequences of prehypertension were increased
in the presence of diabetes mellitus and hypercholestero-
lemia [13].
Prehypertension is a risk factor for overt hypertension,
and several small-scale studies have demonstrated its
association with increased CVD morbidity. Prehyperten-
sion doubles the risk of future CVD events [14]. The risk
of CVD in individuals with prehypertension has not been
thoroughly studied in prediabetic adults. We herein report
the prevalence of prehypertension among prediabetic
Omani adult population and evaluate the relationship
between the CVD risk profiles and blood pressure status
of the subjects. This will be helpful to the health planners
for formulation and implementation of preventive strate-
gies.
Methods
Study population
Three hundred twenty seven confirmed prediabetic
Omani adults (142 males and 185 females) above 18
years of age, who participated in a cross-sectional commu-
nity based study carried out in a semi-urban locality of
Bidbid Wilayat (district), situated about 100 km south of
the capital Muscat during September 2004 to February
2005 formed the material of this study.
Fasting blood glucose, fasting lipid profile, oral glucose
tolerance tests were carried out. The anthropometric,
systolic and diastolic blood pressure measurements were
also carried out. The Medical Research and Ethics Com-
mittee of the College of Medicine and Health Sciences,
Sultan Qaboos University approved the study and all sub-
jects gave their informed consent prior to participating in
the study.
Brachial artery BP (first and fifth Korotkoff sounds) was
measured 3 times consecutively on seated participants
after they had rested 5 minutes with the use of a standard-
ized mercury sphygmomanometer. An appropriately
sized cuff was placed on the right arm, pulse occlusion
pressure was determined, and the cuff was inflated to 20
mm Hg above that pressure. The mean of the last two of
these measurements was used for estimation of BP [15].
The standard definition of hypertension was considered
as systolic blood pressure (SBP) of ≥ 140 mm Hg and/or
diastolic blood pressure (DBP) ≥ 90 mm Hg or current use
of antihypertensive medicines. Prehypertension was
defined as SBP of 120 – 139 mm Hg and/or a DBP of 80–
89 mm Hg. The normotensive was defined as SBP < 120
mm Hg and DBP < 80 mm Hg [8].
The fasting plasma glucose (FPG), Oral glucose tolerance
test (OGTT) levels and the lipid profile were estimated at
the Sultan Qaboos University Hospital (SQUH) according
to standard protocol.
We defined high total cholesterol (TC) as ≥ 5.0 mmol/l;
triglycerides (TG) as ≥ 1.7 mmol/l; LDL cholesterol (LDL-
C) as ≥ 3.0 mmol/l; HDL cholesterol (HDL-C) as ≤ 1.03
mmol/l. The body mass index (BMI) was calculated as
weight/height2 (kg/m2), and over weight was defined by
considering the cutpoint as BMI ≥ 25 kg/m2.
Waist circumference was measured using steel measuring
tape with measurements made half way between the
lower border of the ribs and iliac crest in a horizontal
plane. Hip circumference was measured at the widest
point over the buttock. Waist hip ratio (WHR) was consid-BMC Public Health 2008, 8:108 http://www.biomedcentral.com/1471-2458/8/108
Page 3 of 7
(page number not for citation purposes)
ered abnormal ≥ 0.95 for males and ≥ 0.85 for females
[16].
Individuals who reported a history of diabetes diagnosed
by a physician and who were taking any medicine or insu-
lin for the disease and those who were not on medicine
but their fasting plasma glucose found to be > 7.0 mmol/
l were excluded from the study. Women found pregnant
during the survey period were also excluded from the
study.
Statistical analysis
Descriptive analysis for continuous variables was used to
calculate mean values and standard deviation (SD). Prev-
alence and frequencies were expressed as percentages.
Chi-square tests were used for establishing relationship
between the two categorical variables. Chi-square trend
test was used for trend analysis of proportions. Unpaired
t tests were used for comparing two group means and
analysis of variance (ANOVA) techniques were used for
comparing three group means. When ANOVA provided
the evidence of significant difference between the three
categories then post hoc test namely, Dunnett t test was
used for pairwise group means comparison. The unad-
justed odds ratios (ORs) and their 95% confidence inter-
vals (CI) were calculated for association between the risk
profile categories and hypertensive status of the subjects.
To evaluate the adjusted effects of CVD risk profiles in the
prehypertensive group as compared to normotensive
group, multiple logistic regression models were fitted and
OR with their 95% CI were estimated. The risk profile var-
iables entered in the regression model were age, gender,
BMI, WHR and lipid parameters namely, TC, LDL-C,
HDL-C and TG. For estimating the multivariate adjusted
ORs corresponding to the potential risk factors, we first
fitted the model after including all the risk factor variables
and compared with the adjusted ORs obtained after refit-
ting the model using stepwise regression procedure [17].
A p-value (two tailed) of less than 0.05 was considered as
statistical significant. All data were analyzed with the Sta-
tistical Package for the Social Sciences Software (SPSS ver-
sion 10.0, Inc., Chicago, IL)
Results
Characteristics and lipid profiles of the study population
is shown in Table 1. It is observed that the mean age of the
female prediabetics was more than that of males (P <
0.05). The mean values of the oral glucose tolerance tests
(OGTT), BMI and HDL-C were more in females (p <
0.01). The WHR, SBP, DBP and TG have been found to be
more in males and the differences were statistically signif-
icant (p < 0.05). Further, the analysis of blood pressure of
the study population showed that 54.1% were prehyper-
tensives and 24.2% were hypertensives.
The demographic, metabolic and behavioral characteris-
tics of the study population as per blood pressure groups
are shown in Table 2. It is observed that except for HDL-C
and TG, all other biochemical parameters have shown a
gradual upward trend from normotensive group to prehy-
pertensive and further to hypertensive group. As the blood
pressure increased from normotension to hypertension
group, the average age of the study population showed an
increasing trend. Prehypertensive category had signifi-
cantly higher level of TG and BMI in comparison to nor-
motensive category (p < 0.01). Similarly, hypertensive
subjects had higher level of FPG and LDL-C in compari-
Table 1: Characteristics and lipid profiles of the prediabetic study group
Characteristics Total (n = 327) Male (n = 142) Female (n = 185) p
Mean ± SD Mean ± SD Mean ± SD
Age (years) 35.0 ± 12.0 33.4 ± 12.3 36.2 ± 12.0 0.039
FPG (mmol/L) 5.9 ± 0.4 5.9 ± 0.4 5.8 ± 0.4 0.059
OGT (mmol/L) 7.1 ± 1.8 6.6 ± 1.7 7.6 ± 1.7 <0.001
SBP (mmol/L) 125.7 ± 15.9 128.6 ± 16.4 123.4 ± 15.2 0.003
DBP (mmol/L) 78.9 ± 9.9 80.3 ± 10.0 77.8 ± 9.8 0.027
BMI (kg/m2) 27.1 ± 5.6 26.2 ± 4.7 27.9 ± 6.2 0.004
WHR 0.89 ± 0.08 0.90 ± 0.07 0.88 ± 0.09 0.014
TC (mmol/L) 5.0 ± 1.1 5.0 ± 1.0 5.1 ± 1.1 0.492
LDL-C (mmol/L) 3.4 ± 0.9 3.4 ± 0.9 3.4 ± 0.9 0.595
HDL-C (mmol/L) 1.2 ± 0.3 1.1 ± 0.3 1.3 ± 0.3 <0.001
TG (mmol/L) 0.9 ± 0.6 1.0 ± 0.7 0.8 ± 0.5 <0.001
Smoking history (%) 14.1% 18.3% 10.8% 0.040
BP status (%)
Normotensive 21.7% 16.2% 25.9% 0.024
Prehypertensive 54.1% 53.5% 54.6%
Hypertensive 24.2% 30.3% 19.5%BMC Public Health 2008, 8:108 http://www.biomedcentral.com/1471-2458/8/108
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son to prehypertensive. The proportion of male subjects
increased linearly from 32.4% in normotensive to 42.9%
in prehypertensive and further to 54.4% in hypertensive
group (p < 0.01).
The sexwise distribution of metabolic parameters in dif-
ferent BP groups is shown in Table 3.
It is seen that OGT is higher in females than males
amongst all the three BP groups and the sex differential in
each category were found to be statistically significant (p
< 0.01). HDL-C level in women was significantly higher in
normotensive and prehypertensive as compared to males
(p < 0.05). The BMI was found to be significantly higher
in females in both prehypertension and hypertension
groups as compared to males (p < 0.05).
Sex wise prevalence of risk factors for CVD and estimation
of odds ratios are shown in Table 4. It is found that the
BMI was the strongest modifiable predictor of prehyper-
tension and hypertension in females with OR 4.0 (95%
CI, 1.8, 8.8) and OR 4.0 (95% CI, 1.4, 11.3) respectively.
The TC and LDL-C showed an upward trend in both sexes
amongst the prehypertensive group as compared to nor-
motensive group. The prediabetic male individuals with
lower level of HDL-C (< 1.03 mmol/l) had two fold risk
of being classified as prehypertensive as compared to nor-
motensives. Females with abnormal WHR were found
more at risk for developing hypertension with OR 2.7
(95% CI, 0.9, 8.1).
The determinants of prehypertension versus normoten-
sion based on fitting multiple logistic regression models
in prediabetic subjects are shown in Table 5. The stepwise
logistic regression method revealed that the males were at
higher risk of developing prehypertension as compared to
females with OR 2.30 (95% CI, 1.21, 4.38; p < 0.01). The
individuals with higher BMI have two fold more risk of
developing prehypertension with OR 2.25 (95% CI, 1.26,
4.02; p < 0.01). The analysis also revealed that one unit
increase in the OGT level increases the risk of developing
prehypertension with OR 1.26 (95% CI, 1.06, 1.50; p <
0.01) in prediabetics.
Table 2: Demographic, Metabolic and Behavioral characteristics of prediabetic subjects by BP groups (Mean ± SD)
Variable Normotensive (n = 71) Prehypertensive (n = 177) p* Hypertensive (n = 79) p↑
Age (years) 33.1 ± 9.8 33.2 ± 11.0 0.979 40.7 ± 14.7 <0.001
Sex, male/female 23/48 76/101 0.064 43/36 0.044
FPG, (mmol/L) 5.8 ± 0.4 5.9 ± 0.4 0.263 6.0 ± 0.4 0.050
IGT (mmol/L) 6.7 ± 1.7 7.2 ± 1.8 0.062 7.4 ± 1.8 0.567
TC (mmol/L) 4.8 ± 0.9 5.0 ± 1.0 0.238 5.3 ± 1.2 0.076
LDL-C (mmol/L) 3.3 ± 0.8 3.4 ± 0.9 0.412 3.6 ± 1.0 0.050
HDL-C (mmol/L) 1.2 ± 0.3 1.2 ± 0.3 0.756 1.2 ± 0.4 0.972
TG (mmol/L) 0.7 ± 0.5 0.9 ± 0.6 0.011 0.9 ± 0.6 0.771
BMI (kg/m2) 25.2 ± 4.6 27.6 ± 5.8 0.002 27.7 ± 5.8 0.899
WHR 0.87 ± 0.09 0.89 ± 0.07 0.740 0.92 ± 0.08 0.010
Smoking history % 19.7% 13.0% 0.179 11.4% 0.720
* p-values for comparison between normotensive and prehypertensive subjects
↑ p-values for comparison between prehypertensive and hypertensive subjects
Table 3: Mean age, metabolic parameters and BMI by BP groups and sex
Variable Normotensive (n = 71) Prehypertensive (n = 177) Hypertensive (n = 79)
Males (n = 23) Females (n = 48) Males (n = 76) Females (n = 101) Males (n = 43) Females (n = 36)
Mean ± SD Mean ± SD P Mean ± SD Mean ± SD p Mean ± SD Mean ± SD p
Age (years) 32.3 ± 10.3 33.5 ± 9.7 0.634 30.9 ± 10.2 34.9 ± 11.3 0.018 38.3 ± 15.1 43.5 ± 14.0 0.123
FPG (mmol/L) 5.8 ± 0.3 5.8 ± 0.4 0.402 5.9 ± 0.4 5.8 ± 0.4 0.321 6.0 ± 0.4 6.0 ± 0.4 0.464
IGT (mmol/L) 5.9 ± 1.5 7.1 ± 1.7 0.005 6.6 ± 1.7 7.7 ± 1.7 <0.001 6.9 ± 1.9 7.9 ± 1.6 0.011
TC (mmol/L) 4.6 ± 0.9 4.9 ± 0.9 0.248 5.0 ± 0.9 5.0 ± 1.1 0.951 5.1 ± 1.2 5.4 ± 1.2 0.213
LDL-C (mmol/L) 3.1 ± 0.8 3.3 ± 0.8 0.400 3.4 ± 0.8 3.4 ± 1.0 0.835 3.5 ± 1.1 3.8 ± 1.0 0.183
HDL-C (mmol/L) 1.1 ± 0.2 1.3 ± 0.3 0.005 1.1 ± 0.3 1.3 ± 0.3 <0.001 1.2 ± 0.4 1.2 ± 0.3 0.878
TG (mmol/L) 0.8 ± 0.4 0.6 ± 0.5 0.101 1.1 ± 0.8 0.7 ± 0.5 <0.001 0.9 ± 0.6 1.0 ± 0.6 0.633
BMI, (kg/m2) 25.5 ± 3.9 25.0 ± 4.9 0.703 26.2 ± 4.9 28.7 ± 6.2 0.004 26.4 ± 4.8 29.4 ± 6.6 0.022
WHR 0.91 ± 0.07 0.86 ± 0.10 0.049 0.90 ± 0.08 0.88 ± 0.08 0.133 0.92 ± 0.07 0.92 ± 0.09 0.835BMC Public Health 2008, 8:108 http://www.biomedcentral.com/1471-2458/8/108
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Discussion
The overall prevalence of Prehypertension in prediabetic
Omani population was estimated to be 54.1 percent. It is
marginally higher in females (54.6%) in comparison to
males (53.5%) (Table 1). The main determinants of pre-
hypertension were increasing BMI and blood sugar levels.
The male prediabetics were more susceptible to prehyper-
tension. Hsai et al in their study found a prevalence of
40.3 percent prehypertensives among Asian women [18].
Epidemiological data from National Health and Nutrition
examination survey, USA estimated the prevalence of pre-
hypertension to be 31%. Additionally, more than 88% of
the individuals with prehypertension had at least one car-
dio vascular risk factor [19]. Prevalence estimated in our
study is less than the prevalence of pre-hypertension
reported in the Strong heart study among diabetics [11].
This indicates that prevalence of prehypertension is more
in diabetics than prediabetics.
In a study among young Israeli adult population the prev-
alence of prehypertension has been estimated to be 50.6%
in males and 35.9% in females [14]. Our finding when
compared to all other studies on general population indi-
cates that prevalence of prehypertension is more among
pre-diabetics for both males and females.
In Framingham Heart Study, 6859 participants, who were
initially pre-hypertensive and were followed up for 10
years. The cumulative incidence of CVD in the subjects
between 35 – 64 years was 8% in males and 4% in
females. In older persons above 65 years, it increased to
25% for males and 18% for females [20].
Winegarden [21] in his study estimated Relative Risk (RR)
for an individual becoming a hypertensive from prehyper-
tensive status. He divided prehypertension group into two
subcategories namely, normal (120–129 systolic and/or
80–85 diastolic) and high normal (130–139 systolic and/
or 86–89 diastolic). He estimated RR for the "normal"
subcategory as 2.0 (95% CI, 1.6, 2.6) and for "high nor-
mal" as 2.9 (95% CI, 2.3, 3.7).
In a study of cardiovascular risk factor status, 614 non dia-
betic Mexican American were followed up for 8 years and
43 (7.0%) developed pre-diabetes and had high level of
TC, LDL-C, TG, BMI and BP and lower level of HDL-C
than 571 subjects remained non-diabetic [22]. Similar
finding was also noticed in our study population (Table
1). It is likely that prediabetic subjects have an atherogenic
pattern of risk factors and may contribute to the risk of
macro vascular disease. It has been estimated that if pre-
Table 4: Prevalence of risk factors (%) for CVD by BP groups and gender in the prediabetic subjects
Variable Males (n = 142) Females (n = 185)
Normal 
(n = 23)
Pre-HTN 
(n = 76)
OR 
(95%CI)
HTN 
(n = 43)
OR 
(95%CI)
Normal 
(n = 48)
Pre-HTN 
(n = 100)
OR 
(95%CI)
HTN 
(n = 36)
OR 
(95%CI)
TC (≥5.0 mmol/L) 39.1 51.3 1.6 
(0.6, 4.7)
48.8 1.5 
(0.5,4.7)
43.8 47.0 1.2 
(0.6, 2.4)
63.9 2.3 
(0.9, 6.1)
TG (≥ 1.7 mmol/L) - 23.7 - 11.6 - 4.2 5.1 1.2 
(0.2,9.5)
11.1 2.9 
(0.4,24.3)
LDL-C 
(≥ 3.0 mmol/L)
59.1 71.1 1.7 
(0.6,5.1)
73.7 1.9 
(0.6,6.9)
66.7 71.3 1.3 
(0.6,2.8)
75.0 1.5 
(0.5,4.4)
HDL-C (≤ 1.03 
mmol/L)
34.8 52.6 2.1 
(0.7, 6.2)
32.6 0.9 
(0.3,3.0)
18.8 18.0 1.0 
(0.4,2.5)
25.0 1.5 
(0.5,4.6)
BMI (≥25.0 kg/m2) 60.9 59.2 0.9 
(0.3,2.7)
53.5 0.7 
(0.2,2.3)
39.6 72.3 4.0 
(1.8,8.8)
72.2 4.0 
(1.4,11.3)
Abnormal WHR 
(%)
17.4 31.7 2.2 
(0.6, 8.5)
34.9 2.5 
(0.6, 10.7)
56.3 65.3 1.5 
(0.7, 3.1)
77.8 2.7 
(0.9, 8.1)
Smoking history 
(%)
26.1 18.4 0.6 
(0.2,2.2)
14.0 0.5 
(0.1,1.9)
16.7 8.9 0.5 
(0.2,1.5)
8.3 0.5 
(0.1,2.1)
Table 5: Determinants of prehypertension versus normotension based on fitting multiple logistic regression models in the prediabetic 
subjects
Variable Adjusted ORs after including all the factors in the 
model
Adjusted ORs after eliminating the insignificant factors using 
stepwise regression
OR 95% CI P OR 95% CI P
Male sex 2.41 1.11, 5.21 0.026 2.30 1.21, 4.38 0.011
Blood glucose 
(IGT mmol/l)
1.28 1.06, 1.53 0.009 1.26 1.06, 1.50 0.009
BMI (≥25 kg/m2) 1.87 1.00, 3.50 0.050 2.25 1.26, 4.02 0.006
The OR for blood glucose was continuous and calculated for 1 unit.BMC Public Health 2008, 8:108 http://www.biomedcentral.com/1471-2458/8/108
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hypertension is eliminated, hospital admission would be
reduced by 3.4%, nursing home admission by 6.5% and
death would be reduced by 9.1% [23].
In our study the prehypertensives were found to have
higher level of FPG, OGT, TC, LDL-C, TG and BMI than
normotensives (Table 2, 3, 4). Similar findings were
reported by Liszka et al [19] and Grotto et al [14]. Haffner
et al [12,22] in their two studies reported similar findings
amongst both prehypertensives and prediabetics. This
clustering of risk factors indicates the need of cardiovascu-
lar risk reduction in prehypertensives and prediabetics
through primordial prevention. The stepwise multiple
logistic regression analysis indicated that the individuals
with higher blood sugar, BMI and male sex are at higher
risk of developing prehypertension (Table 5). Israeli et al
found that the BMI is the strongest modifiable predictor
of prehypertension [24].
Prospective observational studies suggest the risk of cardio
vascular death begins at 115/75 mm Hg and doubles for
every 20/10 mm Hg increment in a linear fashion [9].
Life style measures such as medical nutrition therapy and
aerobic exercises modify lipids, reduce blood pressure and
are integral to the management of prediabetes and obes-
ity. Patients with prehypertension and prediabetes should
initiate life style modifications like weight control,
increased physical activity, alcohol moderation, salt
reduction and increased consumption of fresh fruits, veg-
etable and low fat diary product for 3 months [7]. Physical
activities should be at least 150 minutes of moderate
intensity aerobic physical activities or at least 90 minutes
of vigorous exercise per week. If after these efforts, targets
are not achieved, treatment with pharmacological agent
should be initiated [7]. Tobacco cessation intervention
program should be introduced in health centers and hos-
pitals as a routine because it is a priority of state of Art dia-
betic and hypertension care.
Washio et al [25] in their study estimated that in Japanese
population those with prehypertension had an increased
risk of coronary atherosclerosis even after adjusting for
other factors when compared to subjects with normal
blood pressure and concluded that prehypertension is a
clinical entity which requires treatment. In Oman, con-
sanguinity is very common. Hassan et al [26] in their
study, carried out in an urban sample of Omani popula-
tion, found that 26% of the marriages were within their
first cousin. At the national level this figure is very high.
The first cousin marriage under the age of 50 years in 1995
was about 54% of total marriages [26]. This cultural prac-
tice may result into increase in both diabetes and hyper-
tension.
Conclusion
The true question regarding prehypertension amongst
prediabetics is the CVD risk associated with this condition
and anticipated risk reduction to be gained by early initi-
ation of primordial, primary and early diagnosis and
treatment. A long term study will be required to under-
stand the risk associated with prehypertension in predia-
betics and diabetics and role of pharmacological agents to
bring down the BP to 115/75 mm Hg to reduce CVD in
Omani population.
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